“Evaluating the Prevalence of Type 2 Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in the First-degree Family Members of the Diabetic Patients” (2019) Asian Journal of Pharmaceutics (AJP), 12(04). doi:10.22377/ajp.v12i04.2908.